Lip Cancer

• CLINICAL_TRIALS trial_result · 2026-01-29
  Clinical Trial Update: Metformin Hydrochloride and Doxycycline in Treating Patients With Head and Neck Squamous Cell Carcinoma [Phase 2]

  A Phase 2 clinical trial evaluating metformin hydrochloride in combination with doxycycline for head and neck squamous cell carcinoma has be…

• CLINICAL_TRIALS trial_result · 2025-07-20
  Clinical Trial Update: Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN [Phase 2]

  Phase 2 trial evaluating durvalumab with radiotherapy as adjuvant treatment for intermediate-risk squamous cell carcinoma of the head and ne…

• CLINICAL_TRIALS trial_result · 2025-06-06
  Clinical Trial Update: Serum Lipid Profile and Lip Squamous Cell Carcinoma

  The trial has completed its investigation into the relationship between serum lipid profiles and squamous cell carcinoma of the lip/oral reg…

• CLINICAL_TRIALS trial_result · 2025-04-29
  Clinical Trial Update: Nivolumab, Ipilimumab, and Radiation Therapy in Treating Patients With Stage III-IVB Head and Neck Cancer [EARLY_Phase 1]

  This clinical trial update reports early-phase results from a study of nivolumab and ipilimumab with radiation therapy in stage III-IVB head…

• CLINICAL_TRIALS trial_result · 2023-08-03
  Clinical Trial Update: Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene [Phase 1, Phase 2]

  Phase 1/2 clinical trial studying A166 in patients with various HER2-expressing or HER2-amplified cancers has completed.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2023-02-08
  Clinical Trial Update: Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma [Phase 2]

  Phase 2 trial evaluating preoperative and adjuvant therapy with carboplatin, nab-paclitaxel, and durvalumab for head and neck squamous cell …

• CLINICAL_TRIALS trial_result · 2019-11-20
  Clinical Trial Update: Metformin Hydrochloride in Affecting Cytokines and Exosomes in Patients With Head and Neck Cancer [EARLY_Phase 1]

  A completed early-phase trial tested metformin hydrochloride for effects on cytokines and exosomes in patients with head and neck cancers, i…

• CLINICAL_TRIALS trial_result · 2017-05-03
  Clinical Trial Update: Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 2]

  Phase 2 trial examining cisplatin with or without the WEE1 inhibitor MK-1775 in recurrent or metastatic head and neck cancers was terminated…